Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Shitara

Showing results (121-130 of 344) with videos related to

Pageof 35
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 17, 2012
Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatmentKohei Shitara, Yasushi Yatabe, Keitaro Matsuo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2006
[A case of advanced esophageal cancer with suspected tracheoesophageal fistula that responded to chemoradiotherapy]Kohei Shitara, Masaki Munakata, Atushi Ishiguro, et al.
Journal for Immunotherapy of Cancer|October 14, 2018
Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8<sup>+</sup> T cells in the tumor microenvironmentYasuko Tada, Yosuke Togashi, Daisuke Kotani, et al.
Cancer Chemotherapy and Pharmacology|October 21, 2010
Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapyKohei Shitara, Keitaro Matsuo, Isao Oze, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2012
Recursive partitioning analysis for new classification of patients with esophageal cancer treated by chemoradiotherapyMotoo Nomura, Kohei Shitara, Takeshi Kodaira, et al.
Lancet (London, England)|May 4, 2025
Gastric cancerRaghav Sundar, Izuma Nakayama, Sheraz R Markar, et al.
Pathology International|April 2, 2015
Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected caseTakuya Saito, Chihiro Kondo, Kohei Shitara, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2017
NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysisToshihiko Doi, Tetsuya Hamaguchi, Kohei Shitara, et al.
BMC Cancer|July 25, 2012
A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II)Akira Tsuburaya, Satoshi Morita, Yasuhiro Kodera, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 16, 2016
Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patientsAkihito Kawazoe, Takeshi Kuwata, Yasutoshi Kuboki, et al.
Pageof 35

Showing results (121-130 of 344) with videos related to

Sort By:
Pageof 35
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 17, 2012
Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatmentKohei Shitara, Yasushi Yatabe, Keitaro Matsuo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2006
[A case of advanced esophageal cancer with suspected tracheoesophageal fistula that responded to chemoradiotherapy]Kohei Shitara, Masaki Munakata, Atushi Ishiguro, et al.
Journal for Immunotherapy of Cancer|October 14, 2018
Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8<sup>+</sup> T cells in the tumor microenvironmentYasuko Tada, Yosuke Togashi, Daisuke Kotani, et al.
Cancer Chemotherapy and Pharmacology|October 21, 2010
Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapyKohei Shitara, Keitaro Matsuo, Isao Oze, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2012
Recursive partitioning analysis for new classification of patients with esophageal cancer treated by chemoradiotherapyMotoo Nomura, Kohei Shitara, Takeshi Kodaira, et al.
Lancet (London, England)|May 4, 2025
Gastric cancerRaghav Sundar, Izuma Nakayama, Sheraz R Markar, et al.
Pathology International|April 2, 2015
Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected caseTakuya Saito, Chihiro Kondo, Kohei Shitara, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2017
NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysisToshihiko Doi, Tetsuya Hamaguchi, Kohei Shitara, et al.
BMC Cancer|July 25, 2012
A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II)Akira Tsuburaya, Satoshi Morita, Yasuhiro Kodera, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 16, 2016
Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patientsAkihito Kawazoe, Takeshi Kuwata, Yasutoshi Kuboki, et al.
Pageof 35